Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study

被引：0
|
作者：
Moa Lugner
Naveed Sattar
Mervete Miftaraj
Jan Ekelund
Stefan Franzén
Ann-Marie Svensson
Björn Eliasson
机构：
[1] University of Gothenburg,Institute of Medicine
[2] Sahlgrenska University Hospital,Institute of Cardiovascular and Medical Sciences
[3] University of Glasgow,undefined
[4] National Diabetes Register,undefined
[5] Centre of Registers,undefined
来源：
Cardiovascular Diabetology | / 20卷
关键词：
Type 2 diabetes; Epidemiology; Sodium glucose transporter 2 inhibitors; Glucagon‐like peptide-1 receptor agonist; Mortality; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: nationwide observational study
    Lugner, Moa
    Sattar, Naveed
    Miftaraj, Mervete
    Ekelund, Jan
    Franzen, Stefan
    Svensson, Ann-Marie
    Eliasson, Bjoern
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [2] SGLT-2 inhibitors and GLP-1 receptor agonists for Type 2 diabetes
    Davila, Esteban
    Mccormack, James
    ACADEMIC EMERGENCY MEDICINE, 2024, 31 (04) : 408 - 411
  • [3] Socioeconomic position and initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study
    Falkentoft, A. C.
    Andersen, J.
    Malik, M. E.
    Selmer, C.
    Gaede, P. H.
    Staehr, P. B.
    Hlatky, M. A.
    Fosboel, E.
    Koeber, L.
    Torp-Pedersen, C.
    Gislason, G. H.
    Gerds, T. A.
    Shou, M.
    Bruun, N. E.
    Ruwald, A. C.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2622 - 2622
  • [4] Impact of socioeconomic position on initiation of SGLT-2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes - a Danish nationwide observational study
    Falkentoft, Alexander C.
    Andersen, Julie
    Malik, Mariam Elmegaard
    Selmer, Christian
    Gaede, Peter Haulund
    Staehr, Peter Bisgaard
    Hlatky, Mark A.
    Fosbol, Emil
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    Gerds, Thomas Alexander
    Schou, Morten
    Bruun, Niels E.
    Ruwald, Anne-Christine
    LANCET REGIONAL HEALTH-EUROPE, 2022, 14
  • [5] Choosing GLP-1 receptor agonists or SGLT-2 inhibitors by cardiorenal risk
    Bailey, Clifford J.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (02): : 97 - 99
  • [6] SGLT-2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes: BMJ Rapid Recommendation
    Arnold, Michael J.
    Buelt, Andrew
    AMERICAN FAMILY PHYSICIAN, 2022, 105 (06) : 675 - 677
  • [7] Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes
    Norgaard, Caroline H.
    Starkopf, Liis
    Gerds, Thomas A.
    Vestergaard, Peter
    Bonde, Anders N.
    Fosbol, Emil
    Kober, Lars
    Wong, Nathan D.
    Torp-Pedersen, Christian
    Lee, Christina J-Y
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (06) : 549 - 556
  • [8] SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline
    Li, Sheyu
    Vandvik, Per Olav
    Lytvyn, Lyubov
    Guyatt, Gordon H.
    Palmer, Suetonia C.
    Rodriguez-Gutierrez, Rene
    Foroutan, Farid
    Agoritsas, Thomas
    Siemieniuk, Reed A. C.
    Walsh, Michael
    Frere, Lawrie
    Tunnicliffe, David J.
    Nagler, Evi, V
    Manja, Veena
    Asvold, Bjorn Olav
    Jha, Viveekanand
    Vermandere, Mieke
    Gariani, Karim
    Zhao, Qian
    Ren, Yan
    Cartwright, Emma Jane
    Gee, Patrick
    Wickes, Alan
    Ferns, Linda
    Wright, Robin
    Li, Ling
    Hao, Qiukui
    Mustafa, Reem A.
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [9] Management of Type 2 Diabetes Mellitus with Overweight: Focus on SGLT-2 Inhibitors and GLP-1 Receptor Agonists
    Jargin, Sergei V.
    EUROPEAN JOURNAL OF THERAPEUTICS, 2019, 25 (02): : 93 - 96
  • [10] Exploring nontraditional cardiorenal advantages of SGLT-2 inhibitors and GLP-1 receptor agonists
    Chen, Jia-Jin
    Lee, Tao-Han
    Yang, Huang-Yu
    KIDNEY INTERNATIONAL, 2024, 105 (03) : 442 - 444
12345